Diabetes drug may hold potential as treatment for epilepsy

Apr 09, 2008

Metformine, a widely used diabetic drug, might also be an effective and safe therapy for epilepsy, researchers report. This new approach may be especially helpful for the subset of patients who have recurrent seizures despite therapy with the best available drugs.

The basis for metformine’s effect is similar to a ketogenic diet, which is an attempt to minimize dietary starch and sugar. Epilepsy patients have been using this severe dietary approach for centuries, which led Dr. Avtar Roopra and colleagues to wonder if drugs could tap into metabolic pathways and produce similar results.

The researchers identified a small molecule in neurons that senses how much energy is available on hand. Glucose normally turns on this sensor, but so does Metformine, a drug used to control blood sugar. By administering the proper dose, they could suppress over-active nerve cells by removing their ability to turn sugar into excess energy.

Roopra and colleagues now hope to apply their preliminary results to a mouse model of epilepsy.

Source: American Society for Biochemistry and Molecular Biology

Explore further: More than a quarter of emergency contraceptives in Peru falsified or substandard

add to favorites email to friend print save as pdf

Related Stories

Most detailed picture ever of key part of hepatitis C

Nov 28, 2013

Scientists at The Scripps Research Institute (TSRI) have determined the most detailed picture yet of a crucial part of the hepatitis C virus, which the virus uses to infect liver cells. The new data reveal ...

Less toxic metabolites, more chemical product

Oct 29, 2013

The first dynamic regulatory system that prevents the build-up of toxic metabolites in engineered microbes has been reported by a team of researchers with the U.S. Department of Energy (DOE)'s Joint BioEnergy ...

Nanosensors could aid drug manufacturing

Aug 16, 2013

MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs—especially those based on antibodies—more ...

Recommended for you

Study recalculates costs of combination vaccines

Apr 17, 2014

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

User comments : 0

More news stories

Treating depression in Parkinson's patients

A group of scientists from the University of Kentucky College of Medicine and the Sanders-Brown Center on Aging has found interesting new information in a study on depression and neuropsychological function in Parkinson's ...

Impact glass stores biodata for millions of years

(Phys.org) —Bits of plant life encapsulated in molten glass by asteroid and comet impacts millions of years ago give geologists information about climate and life forms on the ancient Earth. Scientists ...

Airbnb rental site raises $450 mn

Online lodging listings website Airbnb inked a $450 million funding deal with investors led by TPG, a source close to the matter said Friday.